|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR RENAL TOXICITY, BRONCHOSPASM, AND HYPOTENSION
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
PROBENECID INCREASES THE SERUM LEVELS OF THE DRUG
|
PROTAMINE SULPHATE HAS BEEN SEEN TO BE INCOMPATIBLE WITH CERTAIN ANTIBIOTICS INCLUDING SEVERAL OF CEPHALOSPORINS & PENICILLINS
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR RENAL TOXICITY, BRONCHOSPASM, AND HYPOTENSION
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|